8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 23, 2015

Bio-Reference Laboratories, Inc.

(Exact name of registrant as specified in its charter)

New Jersey	0-15266	22-2405059
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

481 Edward H. Ross Drive, Elmwood Park, NJ	07407
(Address of principal executive offices)	(Zip Code)

(201) 791-2600

Registrant’s telephone number, including area code

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14-d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.02           Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective as of April 23, 2015, Bio-Reference Laboratories, Inc. (the “Company”) and Mr. Howard Dubinett, the Company’s Executive Vice President and Chief Operating Officer, entered into a First Extension of Employment Agreement (the “Amendment”) to Mr. Dubinett’s Employment Agreement, which was originally dated February 1, 2012 (the “Original Employment Agreement”). The Amendment, which is retroactive and effective as of January 29, 2015, extends the term of Mr. Dubinett’s employment with the Company from January 31, 2015 to January 31, 2017. Except for this amendment, the remaining terms of the Original Employment Agreement remain in full force and effect.

This summary description is qualified in its entirety by reference to the Amendment, which is filed as 10.1 to this Form 8-K and is incorporated herein by reference.

Item 9.01.             Financial Statements and Exhibits.

(d)           Exhibits.

10.1First Extension Of Employment Agreement dated as of April 23, 2015 by and between Bio-Reference Laboratories, Inc. and Mr. Howard Dubinett.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 29, 2015	BIO-REFERENCE LABORATORIES, INC.
	By:	/s/ Marc D. Grodman
		Name: Marc D. Grodman, MD
		Title: Chairman of the Board, President and
		Chief Executive Officer

3

Exhibit Index

10.1First Extension Of Employment Agreement dated as of April 23, 2015 by and between Bio-Reference Laboratories, Inc. and Mr. Howard Dubinett.

4

EX-10.1

Exhibit 10.1

FIRST EXTENSION OF EMPLOYMENT AGREEMENT

This First Extension of Employment Agreement (the “First Extension” dated April 23, 2015, and by vote of the Compensation Committee of the Board of Directors of Bio-Reference Laboratories, Inc., to be retroactive to and effective January 29, 2015, is made between Bio-Reference Laboratories, Inc., a New Jersey Corporation with its principal place of business at 481 Edward H. Ross Drive, Elmwood Park, New Jersey 07407 (the “Company”) and Howard Dubinett (the “Employee”).

WITNESSETH:

WHEREAS, the Company and the Employee entered into an Employment Agreement effective February 1, 2012 (the “Employment Agreement”) which is attached hereto and made a part hereof as an attachment; and

WHEREAS, the Company and the Employee intend to extend that Employment Agreement by this First Extension as set forth in this First Extension;

NOW, THEREFORE, in consideration of the mutual covenants herein contained, the parties agree as follows:

1.  The parties hereby modify Paragraph 1 of the Employment Agreement to read as follows:

“1.  Term of Employment.  The Company agrees to continue to employ the Employee as its Executive Vice President and Chief Operating Officer, and the Employee agrees to continue his employment with the Company, for a period commencing as of the Effective Date through January 31, 2017 (the “Expiration Date”), unless earlier terminated in accordance with Section 5 hereof.  The period of time between the Effective Date and the termination of the Employee’s employment hereunder shall be referred to herein as the “Employment Period”.”

2.  The parties and each of them acknowledge, understand and agree that all terms and conditions of the Employment Agreement have been carried out to date as set forth in the Employment Agreement.

3.  The parties and each of them confirm, ratify and affirm all other terms and conditions of the Employment Agreement as if recited herein.

IN WITNESS WHEREOF, the parties have executed this First Extension on the Effective Date stated hereinabove.

COMPANY:
Bio-Reference Laboratories, Inc.
By:	/s/ Marc D. Grodman
	Marc D. Grodman, M.D.
	Chief Executive Officer
	Duly Authorized
EMPLOYEE:
	/s/ Howard Dubinett
Howard Dubinett